National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2026-04326"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2026-04326"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2026-03-05"
last_updated: "2026-03-05"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2026-04326"
document_type: "notice"
publication_date: "2026-03-05"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "91 FR 10812"
fr_volume: 91
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Advisory Board, March 16, 2026, 08:00 a.m. to March 17, 2026, 06:00 p.m., National Cancer Institute—Shady Grove, Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 which was published in the *Federal Register* on January 14, 2026, FR Doc. 2026-00602, 91 FR 1544.

The meeting is amended to change the start and end times of the March 17, 2026, meeting. The open session will be changed from 8:00 a.m.-4:30 p.m. to 9:00 a.m.-3:30 p.m., and the closed session will be changed from 4:45 p.m.-6:00 p.m. to 3:40 p.m.-5:00 p.m. The March 16, 2026, meeting time remains the same. The meeting is partially Closed to the public.

Dated: March 2, 2026.

David W. Freeman,

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.